Background: mutations are a common finding in malignant melanoma (MM). Nevertheless, apart from their significance as a therapeutic target in advanced melanoma, their prognostic value is still debated.
Objective: To assess mutation status in primary, recurrent, or metastatic MM and its correlations with histopathological findings.